CN105688070A - Medicine composition for treating postpartum depression - Google Patents

Medicine composition for treating postpartum depression Download PDF

Info

Publication number
CN105688070A
CN105688070A CN201610159883.XA CN201610159883A CN105688070A CN 105688070 A CN105688070 A CN 105688070A CN 201610159883 A CN201610159883 A CN 201610159883A CN 105688070 A CN105688070 A CN 105688070A
Authority
CN
China
Prior art keywords
parts
radix
medicine composition
chinese medicine
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610159883.XA
Other languages
Chinese (zh)
Inventor
陈霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610159883.XA priority Critical patent/CN105688070A/en
Publication of CN105688070A publication Critical patent/CN105688070A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/69Polygalaceae (Milkwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/72Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725Ziziphus, e.g. jujube
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine composition for treating postpartum depression. The medicine composition is prepared from rhizoma acori graminei, dwarf lilyturf roots, rhizoma ligustici wallichii, poria cocos, wild jujube seeds, fruit of Chinese magnoliavine, radix salviae miltiorrhizae, radix curcumae, pericarpium citri reticulatae, fructus aurantii, polygala tenuifolia, liquorice roots, herba menthae and flos chrysanthemi. The medicine composition has a good effect for treating postpartum depression, and the untoward effect is less than that of common antidepressant of western medicine.

Description

A kind of pharmaceutical composition treating postpartum depression
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of pharmaceutical composition for treating postpartum depression。
Background technology
Postpartum depression is puerpera with the low mood disorders for principal character of mental state。Primary disease sickness rate is higher, and along with socioeconomic development presents the trend continuing to raise。Postpartum depression not only has a strong impact on the physical and mental health of puerpera, and affects development and the family harmony of the emotion of baby, intelligence and behavior。Postpartum depression can develop into major depression, hallucination, autotomy occurs, commits suiside or infanticide, and it is even lifelong that the course of disease can delay several months to the several years。Therefore, the clinical intervention that the needs of patients of postpartum depression is positive, to alleviate or to eliminate postpartum depression symptom as early as possible and to reduce the risk of recurrence。At present that the Study of Etiology of postpartum depression is not yet clear and definite, therefore there is no unified therapeutic scheme clinically。
Summary of the invention
The goal of the invention of the present invention is to provide a kind of Chinese medicine composition treating postpartum depression, to solve the problem that existing Therapeutic Method is imprecise and side effect is big。
The pharmaceutical composition of the present invention is by weight ratio: Rhizoma Acori Graminei, Radix Ophiopogonis, Rhizoma Chuanxiong, Poria, Semen Ziziphi Spinosae, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Radix Curcumae, Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Polygalae, Radix Glycyrrhizae, Herba Menthae, Flos Chrysanthemi。
The pharmaceutical composition of the present invention is by weight ratio: Rhizoma Acori Graminei 25 parts, Radix Ophiopogonis 25 parts, Rhizoma Chuanxiong 25 parts, 20 parts of Poria, Semen Ziziphi Spinosae 20 parts, Fructus Schisandrae Chinensis 20 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Curcumae 20 parts, Pericarpium Citri Reticulatae 18 parts, Fructus Aurantii 18 parts, Radix Polygalae 15 parts, 15 parts of Radix Glycyrrhizae, Herba Menthae 15 parts, Flos Chrysanthemi 15 parts。
The preparation method of above pharmaceutical composition is: take the mixing of above pharmaceutical composition crude drug, it is ground into 10~20 order coarse granules, add 60% ethanol 6 times (volume), extracting three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, and clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, dried cream powder is broken, adds proper auxiliary materials, makes corresponding dosage form。
Adjuvant in the present invention can be acceptable any excipient or carrier on pharmaceutics。
Rhizoma Acori Graminei: have one's ideas straightened out, allay excitement, removing dampness to restore normal function of the stomach。Modern pharmacy research proves, Rhizoma Acori Graminei has the effects such as calmness, cooling, spasmolytic, antifungal。
Radix Ophiopogonis: YIN nourishing and the production of body fluid promoting, lung moistening clear away heart-fire。Modern pharmacy research proves, Radix Ophiopogonis containing multiple steroid saponin, Radix Ophiopogonis Saponin A, B, C, D, glycoside unit is ruscogenin, separately containing ophiopogonin B ', C ', D ', glycoside unit is diosgenin;Still containing multiple flavone compound, as Radix Ophiopogonis methyl yellow alkanone A, B, Radix Ophiopogonis flavanone A, ophiopogonone A, B, methyl ophiopogonone A, B etc., have calmness, improve immunity, fatigue-resisting function。
Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping。Modern pharmacy research proves, Chuanxiong bioalkali, ferulic acid and cnidium lactone have spasmolysis, and ligustilide is then the main component of spasmolytic, and large intestine, dysentery (Song Nei Shi), deformation, green pus, typhoid fever, Salmonella paratyphi and vibrio cholera etc. are had inhibitory action。Some pathogenic dermatophytes is in vitro also had inhibitory action by Rhizoma Chuanxiong water logging agent (1: 3)。Having obvious analgesic activity, sodium ferulate can reduce H2O2And O2The lipid peroxidation caused, has oh resistant and the effect of malonaldehyde (MDA) haemolysis。Sodium ferulate can obviously reduce complement hemolysis, it is suppressed that the combination of complement component 3 b (C36) and erythrocyte membrane。
Poria: eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming。Modern pharmacy research proves, Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect。
Semen Ziziphi Spinosae: tranquilizing by nourishing the heart, tonifying YIN arresting sweating。Modern pharmacy research proves, Semen Ziziphi Spinosae has the effects such as calmness, hypnosis, stable, analgesia。
Fructus Schisandrae Chinensis: restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming。Modern pharmacy research proves, schisandrol extract can reduce the laboratory animal glutamate pyruvate transaminase that caused by carbon tetrachloride, thioethanolamine etc. and raise. and wuweizisu B (schisandrin B) has anti-liver injury effect, also has stable, heart tonifying, enhancing immunity, the effect such as antibacterial。
Radix Salviae Miltiorrhizae: nourishing blood to tranquillize the mind, blood circulation promoting and blood stasis dispelling。Modern pharmacy research proves, Radix Salviae Miltiorrhizae contains TANSHINONES, salvianolic acid, flavone, the material such as triterpene, sterol, can strengthen myocardial contraction, improve cardiac function, does not increase myocardial oxygen consumption。
Radix Curcumae: regulating qi to disperse stagnation, heart fire-clearing upset-relieving。Modern pharmacy research proves, Radix Curcumae is containing volatile oil, wherein there are camphene, Camphora, curcumene, also containing curcumin, demethoxycurcumin, bisdemethoxycurcumin, turmerone and aryl turmerone, still contain starch, fatty oil, rubber, weld, Eucarvone and phellandrene etc., there is the effects such as antifungal。
Pericarpium Citri Reticulatae: in regulating qi-flowing for strengthening spleen, tune。Modern pharmacy research proves that gastrointestinal tract is had the stimulation of gentleness by volatile oil contained by Pericarpium Citri Reticulatae, can the secretion of facilitating digestion liquid, get rid of pneumatosis in intestinal tube, also there is the effect such as defying age, antioxidation。
Fructus Aurantii: dispelling the stagnated QI, row expectorant, removing food stagnancy。Modern pharmacy research proves, Fructus Aurantii has the effect of antiallergic action。
Radix Polygalae: Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, subside a swelling。Modern pharmacy research proves, Radix Polygalae have eliminate the phlegm, calmness, the effect such as analgesia。
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription。Modern pharmacy research proves, Radix Glycyrrhizae has antiinflammatory, antiallergic action, antianaphylactic effect, and licoflavone, Radix Glycyrrhizae extractum and enoxolone all have obvious antitussive effect。
Herba Menthae: wind-dispelling heat-dissipating, refresh oneself, throat。Modern pharmacy research proves, Herba Menthae contains menthol, and this material has antipruritic, pain relieving, anticorrosion, stimulation, anesthesia, refrigerant and antiinflammatory action。
Flos Chrysanthemi: dissipate wind heat clearing away, suppressing the hyperactive liver improving eyesight。Modern pharmacy research proves, Flos Chrysanthemi has the effect of antiviral, and foreign study scholar finds, herpes simplex virus poliovirus and Measles virus are had inhibitory action in various degree by Flos Chrysanthemi。Additionally, also have the effect such as antiinflammatory, antitumor。
In order to show that postpartum depression is had good therapeutic effect by the present invention, carry out following clinical trial:
1. data and method
1.1 physical data: my institute's department of obstetrics and gynecology Hospitalized puerpera in June ,-2015 in June, 2014, wherein 52 example patients with postpartum depression, age 19-42 year, average 25.3 years old。It is divided into two groups according to Therapeutic Method different random, western medicine group 26 example, treatment by Chinese herbs group 26 example。
1.2 diagnostic criterias: with reference to the 7th edition " obstetrics and gynecology ", the standard of the Puerperous Depression that Americanism association formulates at " diagnostic & statistical manual of mental sickness "。There is the symptom of following 5 or more than 5 of appearance in 2 weeks puerperal。(must possess 1. 2. two) is 1. in a very depressed state;2. whole or most activities are substantially lacked interest or joyful;3. body weight is remarkably decreased or increases;4. insomnia or hypersomnia;5. psychomotor excitement or sluggishness;6. tired or weak;7. all feel meaningless when anything crops up or have inferiority complex;8. thinking ability goes down or absent minded;9. idea that is dead or that commit suiside occurs repeatedly。Fell ill within 4 weeks puerperal。
1.3 Therapeutic Method: Western medicine group: with serotonin reuptake inhibithors fluoxetine or tricyclic antidepressant amitriptyline。4~6 weeks medicine times are not etc.。Chinese drug-treated group: the embodiment of the present invention 1 granule, each two bags, every day three times, the course for the treatment of is 4~6 weeks。
1.4 curative effects are passed judgment on
Each patient is evaluated curative effect by improvement degree average after the treatment of 9 symptoms of primary disease diagnostic criteria。Each severe symptom 2 points, the lighter 1 point, symptom without or disappearance person 0 point。After treatment, total score reduces by more than 6 points persons is effective, reduces 3~5 and is divided into effectively, and reducing by 0~2 point of person is DeGrain。The average mark that after contrasting two groups of patient, symptom is improved。With statistical method comparing difference significance。And record frequency and degree that relevant Drug side reaction occurs。
2. result
2.1 comparitive study:
Western medicine group effect shows author 12 example, responder 8 example, DeGrain person 6 example。
Chinese drug-treated group effect shows author 13 example, responder 8 example, DeGrain person 5 example。
Statistical analysis, two groups of curative effect no difference of science of statistics。
2.2 adverse effectes:
In Western medicine group, 9 examples occur that side effect is lassitude on daytime, drowsiness, account for 34.62%。
In Chinese drug-treated group 26 example, without lethargy and drowsiness person on daytime occurs。
Clinical trial shows that medicine of the present invention has the effect of good treatment postpartum depression, similar with Western medicine fluoxetine or amitriptyline effect on the whole, but there is no obvious adverse reaction。Antidepressant fluoxetine or amitriptyline that Chinese medicine preparation of the present invention is better than commonly using are described。
Specific embodiment
Embodiment 1 Rhizoma Acori Graminei 25g, Radix Ophiopogonis 25g, Rhizoma Chuanxiong 25g, Poria 20g, Semen Ziziphi Spinosae 20g, Fructus Schisandrae Chinensis 20g, Radix Salviae Miltiorrhizae 20g, Radix Curcumae 20g, Pericarpium Citri Reticulatae 18g, Fructus Aurantii 18g, Radix Polygalae 15g, Radix Glycyrrhizae 15g, Herba Menthae 15g, Flos Chrysanthemi 15g
The preparation method of granule of the present invention: take the mixing of above pharmaceutical composition crude drug, it is ground into 10~20 order coarse granules, add 60% ethanol 6 times (volume), extract three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, dried cream powder is broken, adds amylum pregelatinisatum 500g, sodium carboxymethyl cellulose 250g, mixed 80 mesh sieves, adds suitable quantity of water and granulates, 60 DEG C of drying under reduced pressure, granulate, is distributed into 100 bags, to obtain final product。
Embodiment 2 Rhizoma Acori Graminei 25g, Radix Ophiopogonis 25g, Rhizoma Chuanxiong 25g, Poria 20g, Semen Ziziphi Spinosae 20g, Fructus Schisandrae Chinensis 20g, Radix Salviae Miltiorrhizae 20g, Radix Curcumae 20g, Pericarpium Citri Reticulatae 18g, Fructus Aurantii 18g, Radix Polygalae 15g, Radix Glycyrrhizae 15g, Herba Menthae 15g, Flos Chrysanthemi 15g
The preparation method of hard capsule of the present invention: take the mixing of above pharmaceutical composition crude drug, it is ground into 10~20 order coarse granules, add 60% ethanol 6 times (volume), extracting three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, and clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, dried cream powder is broken, loads capsule, to obtain final product。
Embodiment 3 Rhizoma Acori Graminei 25g, Radix Ophiopogonis 25g, Rhizoma Chuanxiong 25g, Poria 20g, Semen Ziziphi Spinosae 20g, Fructus Schisandrae Chinensis 20g, Radix Salviae Miltiorrhizae 20g, Radix Curcumae 20g, Pericarpium Citri Reticulatae 18g, Fructus Aurantii 18g, Radix Polygalae 15g, Radix Glycyrrhizae 15g, Herba Menthae 15g, Flos Chrysanthemi 15g
The preparation method of Tablets: take the mixing of above pharmaceutical composition crude drug, be ground into 10~20 order coarse granules, add 60% ethanol 6 times (volume), extract three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, and clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, dried cream powder is broken, add starch, Pulvis Talci and Magnesium Stearate proper quantity, granulate, tabletted, coating, to obtain final product。

Claims (5)

1. the Chinese medicine composition treating postpartum depression, it is characterised in that the raw material making this pharmaceutical composition active component is: Rhizoma Acori Graminei, Radix Ophiopogonis, Rhizoma Chuanxiong, Poria, Semen Ziziphi Spinosae, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Radix Curcumae, Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Polygalae, Radix Glycyrrhizae, Herba Menthae, Flos Chrysanthemi。
2. Chinese medicine composition as claimed in claim 1, it is characterized in that in parts by weight, the raw material making this pharmaceutical composition active component is: Rhizoma Acori Graminei 25 parts, Radix Ophiopogonis 25 parts, Rhizoma Chuanxiong 25 parts, 20 parts of Poria, Semen Ziziphi Spinosae 20 parts, Fructus Schisandrae Chinensis 20 parts, Radix Salviae Miltiorrhizae 20 parts, Radix Curcumae 20 parts, Pericarpium Citri Reticulatae 18 parts, Fructus Aurantii 18 parts, Radix Polygalae 15 parts, 15 parts of Radix Glycyrrhizae, Herba Menthae 15 parts, Flos Chrysanthemi 15 parts。
3. Chinese medicine composition as claimed in claim 1 or 2, it is characterised in that it is granule, tablet or capsule。
4. Chinese medicine composition as claimed in claim 3, it is characterized in that method for making is as follows: take the mixing of described pharmaceutical composition crude drug, it is ground into 10~20 order coarse granules, adds 60% ethanol 6 times (volume), extract three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, and dried cream powder is broken, add proper auxiliary materials, make corresponding dosage form。
5. Chinese medicine composition as claimed in claim 4, it is characterized in that method for making is as follows: take Rhizoma Acori Graminei 25g, Radix Ophiopogonis 25g, Rhizoma Chuanxiong 25g, Poria 20g, Semen Ziziphi Spinosae 20g, Fructus Schisandrae Chinensis 20g, Radix Salviae Miltiorrhizae 20g, Radix Curcumae 20g, Pericarpium Citri Reticulatae 18g, Fructus Aurantii 18g, Radix Polygalae 15g, Radix Glycyrrhizae 15g, Herba Menthae 15g, Flos Chrysanthemi 15g, mixing, it is ground into 10~20 order coarse granules, add 60% ethanol 6 times (volume), extract three times with continuous 60 DEG C of microwave assisted extraction methods, extract is centrifuged separating, clean immersion is concentrated into the thick paste that relative density is 1.20~1.30, vacuum drying, dried cream powder is broken, add amylum pregelatinisatum 500g, sodium carboxymethyl cellulose 250g, mixed 80 mesh sieves, add suitable quantity of water to granulate, 60 DEG C of drying under reduced pressure, granulate, it is distributed into 100 bags。
CN201610159883.XA 2016-03-14 2016-03-14 Medicine composition for treating postpartum depression Pending CN105688070A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610159883.XA CN105688070A (en) 2016-03-14 2016-03-14 Medicine composition for treating postpartum depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610159883.XA CN105688070A (en) 2016-03-14 2016-03-14 Medicine composition for treating postpartum depression

Publications (1)

Publication Number Publication Date
CN105688070A true CN105688070A (en) 2016-06-22

Family

ID=56231473

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610159883.XA Pending CN105688070A (en) 2016-03-14 2016-03-14 Medicine composition for treating postpartum depression

Country Status (1)

Country Link
CN (1) CN105688070A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106266962A (en) * 2016-08-31 2017-01-04 牟美玲 A kind of medicament composing prescription for the nursing of puerpera's postpartum depression and preparation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101085231A (en) * 2007-06-20 2007-12-12 济南新境界企业管理咨询有限公司 Internal-applied traditional Chinese medicine composition for treating depression
CN101530599A (en) * 2009-04-20 2009-09-16 高新华 A pharmaceutical composition for treating mental depression
CN102188603A (en) * 2010-03-02 2011-09-21 许沪铭 Traditional Chinese medicine capable of mitigating brain fatigue

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101085231A (en) * 2007-06-20 2007-12-12 济南新境界企业管理咨询有限公司 Internal-applied traditional Chinese medicine composition for treating depression
CN101530599A (en) * 2009-04-20 2009-09-16 高新华 A pharmaceutical composition for treating mental depression
CN102188603A (en) * 2010-03-02 2011-09-21 许沪铭 Traditional Chinese medicine capable of mitigating brain fatigue

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黄胜: "舒郁汤加减治疗抑郁症疗效观察", 《海南医学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106266962A (en) * 2016-08-31 2017-01-04 牟美玲 A kind of medicament composing prescription for the nursing of puerpera's postpartum depression and preparation method

Similar Documents

Publication Publication Date Title
CN101433701B (en) Chinese medicament preparation for treating children's anorexia and preparation method
CN113577230A (en) Composition for preventing and delaying occurrence and development of senile dementia and application thereof
CN101485796A (en) Chinese medicinal composition for treating insomnia as well as preparation method and quality control method thereof
CN101837087B (en) Chinese medicinal composition for improving immunity, resisting fatigue and improving sexual function
CN103520293A (en) Oral traditional Chinese medicine for improving and treating constipation
CN107773609A (en) It is a kind of that there is the pharmaceutical composition and its preparation for improving sleep function
CN116370556B (en) Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis, tonifying qi and soothing nerves and preparation method thereof
CN102552806B (en) Fat-burning dredging particles and preparation method thereof
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN103446445B (en) Traditional Chinese medicine preparation for treating qi-yin deficiency-type chronic bronchitis and preparation method thereof
CN105688070A (en) Medicine composition for treating postpartum depression
CN104126706A (en) Arrhythmia-conditioning tea
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN101919924B (en) Pharmaceutical composition for curing tristimania and preparation method and application thereof
CN104721629B (en) A kind of Chinese medicine preparation and preparation method for the treatment of iron Deficiency Anemia
CN104337909B (en) A kind of Chinese medicine composition of the treatment gout containing Aspongopus
CN106266962A (en) A kind of medicament composing prescription for the nursing of puerpera's postpartum depression and preparation method
CN104055845A (en) Composition for treating diseases of heart and cerebral vessel, liver and kidney and boosting immunity and preparation thereof
CN104606636B (en) A kind of Chinese medicine composition for treating depression and preparation method thereof
TW202009011A (en) Composition for nourishing yin and tonifying kidney and preparation method and applications thereof
CN117159658B (en) A Chinese medicinal composition for preventing, relieving or treating intractable insomnia, and its preparation method
CN108210588A (en) A kind of pharmaceutical composition and preparation method with tranquilizing effect
CN102416147B (en) Medicinal composition for treating mania of patients abstained from drugs
CN105288088A (en) Pharmaceutical composition for prevention and control of chronic nonbacterial prostatitis and application thereof
CN104398564A (en) Tripterygium wilfordii containing Chinese medicinal composition for treatment of gout

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160622

RJ01 Rejection of invention patent application after publication